Wolverine Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Wolverine Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-29,352	Closed	-$840K	–	1881
2018 Q4	$840K	Sell	29,352 -53,550	-65%	-$1.52M	0.01%	879
2018 Q3	$2.31M	Hold	82,902	–	–	0.03%	539
2018 Q2	$2.31M	Buy	82,902 +600	+0.7%	+$16.1K	0.03%	480
2018 Q1	$2.05M	Sell	82,302 -33,278	-29%	-$809K	0.03%	520
2017 Q4	$2.8M	Buy	115,580 +78,380	+211%	+$2.07M	0.03%	417
2017 Q3	$1.03M	Buy	+37,200	New	+$992K	0.01%	649
2014 Q1	–	Sell	-7,500	Closed	-$75K	–	2926
2013 Q4	$75K	Buy	+7,500	New	+$85.1K	﹤0.01%	1610

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Wolverine Asset Management's NXTM Position: Q1 2019 in Review

Wolverine Asset Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 29,352 shares — an estimated $840K sold.

Wolverine Asset Management first reported a position in NXTM in Q4 2013 and held it in 7 quarters. The position peaked at $2.8M in Q4 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Wolverine Asset Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Wolverine Asset Management sold 29,352 NxStage Medical Inc. shares in Q1 2019, an estimated $840K.
Wolverine Asset Management first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 7 quarters.
Wolverine Asset Management's NxStage Medical Inc. position peaked at $2.8M in Q4 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Wolverine Asset Management's 13F filing for Q1 2019, filed 15 May 2019.